Hsp90 is implicated in increasing the survival of breast cancer cells by stabilising oncogenic proteins [48] including Bcl-2, and if targeted, can allow tumour cells to overcome apoptotic resistance through Hsp90-Bcl-2 interactions [49]. This evidence concerns the gene BCL2 and neoplasm.